课题基金 / 基金详情

The Promiscuity of EpoC Towards Polymer Bound Substrates

The Promiscuity of EpoC Towards Polymer Bound Substrates
EpoC 对聚合物结合基底的混杂性
批准号:
6984779
负责人:
Zachary David Aron
金额:
$4.6万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-01-03 至 2007-09-02

项目摘要

项目成果

Zachary David Aron的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Small molecule peptide, polyketide and hybrid polyketide/polypeptide natural products are characterized by their potent biological activities and modular biosyntheses. These compounds typically are generated by modular polyketide synthase (PKS), nonribosomal peptide synthetase (NRPS) and hybrid NRPS/PKS enzymes. To date, there has been limited study of the NRPS/PKS interface of hybrid NRPS/PKS enzymes. This proposal seeks to examine the NRPS/PKS interface of epothilone synthase by exploring the promiscuity of the ketosynthase (KS) domain of epoC towards solid phase bound peptide substrates. EpoC, which sits at the hybrid NRPS/PKS interface of epothilone synthase, was chosen for this study because of the pharmaceutical significance of the epothilones and the extensive body of work regarding their biosynthesis. By applying this technology to libraries of peptide substrates a detailed understanding of the substrate specificity of epoC will be developed, opening the door to reengineering epothilone biosynthesis to generation of novel epothilone derivatives. Also, by fusing epoC to additional PKS modules, combinatorial libraries of hybrid polypeptide/polyketide molecules can be accessed for drug discovery by semibiosynthesis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of a New Class of Hepatitis B Virus Inhibitors that Induce a Novel Defective Nucleocapsid Phenotype
  • 批准号:
    10081385
  • 项目类别:
  • 资助金额:
    $29.85万
  • 财政年份:
    2020
  • 负责人:
    Zachary David Aron
  • 依托单位:
Development of a New Class of Hepatitis B Virus Inhibitors that Induce a Novel Defective Nucleocapsid Phenotype
  • 批准号:
    10220712
  • 项目类别:
  • 资助金额:
    $29.83万
  • 财政年份:
    2020
  • 负责人:
    Zachary David Aron
  • 依托单位:
EF-Tu binding Tetrazoles targeting MDR Neisseria gonorrhoeae
  • 批准号:
    9753119
  • 项目类别:
  • 资助金额:
    $29.97万
  • 财政年份:
    2018
  • 负责人:
    Zachary David Aron
  • 依托单位:
Oxadiazole Inhibitors of Non-Stop Ribosome Rescue to treat MDR Neisseria gonorrhoeae
  • 批准号:
    9975690
  • 项目类别:
  • 资助金额:
    $105.81万
  • 财政年份:
    2017
  • 负责人:
    Zachary David Aron
  • 依托单位:
海外基金